Plavsic Mark 4
4 · FATE THERAPEUTICS INC · Filed Nov 22, 2021
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Award
Common Stock
2021-11-19+59,540→ 97,540 total
Footnotes (1)
- [F1]These shares were granted pursuant to a performance-based restricted stock unit award. The units will vest in three approximately equal installments conditioned upon the achievement, on or before December 31, 2026, of up to three specified late-stage clinical and regulatory milestones of the issuer, so long as the reporting person continues to serve as an employee of the issuer through each milestone achievement.